Trial Profile
Comparison of Biofreedom polymer-free umirolimus-coated stent and Biomatrix drug-eluting stent
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 21 Oct 2015
Price :
$35
*
At a glance
- Drugs Umirolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- 21 Oct 2015 New trial record
- 02 Sep 2015 Results presented at ESC Congress 2015: Annual Congress of the European Society of Cardiology.